BRIEF REPORT
Ayodeji Otufowora, MD, PhD, MPH; Kathleen L. Egan, PhD, MS; Piyush V. Chaudhari, MS; Aderonke A. Okusanya, MSHS; Afeez O. Ogidan, MBChB; Linda B. Cottler, PhD, MPH, FACE
Corresponding Author: Ayodeji Otufowora, MD, PhD, MPH; Department of Pediatrics, Columbia University Medical Center, Columbia University
Email: ao2895@cumc.columbia.edu
DOI: 10.3122/jabfm.2023.230227R1
Keywords: Drug Deactivation Pouches, Drug Overdose, Feasibility Studies, Florida, Intention, Opioids, Substance-Related Disorders
Dates: Submitted: 06-10-2023; Revised: 09-07-2023; Accepted: 09-18-2023
AHEAD OF PRINT: |HTML| |PDF| FINAL PUBLICATION: |HTML| |PDF|
IMPORTANCE: A substantial number of opioid analgesics dispensed into communities will go unused and be susceptible to diversion for misuse. Convenient, efficient, and environmentally safe mechanisms for disposal are needed to prevent the diversion of unused opioid analgesics.
OBJECTIVE: This initiative piloted the feasibility of distributing drug deactivation pouches in a community setting and examined community members’ acceptance, intention to use drug deactivation pouches, and their current disposal practices of unused opioid analgesics. Although many studies have examined the benefits of deactivation pouches in preventing drug overdose, few have explored community members’ perspectives, the feasibility, and the acceptability of these pouches in disposing of unused medications.
METHODS: In the fall of 2017, we piloted the distribution of drug deactivation pouches to assess the overall interest in the pouches at a 3-day community event and continued the second wave of this pilot in the community from the summer of 2018 to the spring of 2019.
Our main outcomes and measures included the acceptance of the drug deactivation pouches and the intention to use the pouches. “Acceptance” was defined as study participants physically taking the kit and “Intention” was how participants intended to use the pouch.
RESULTS: A total of 170 community members were approached at a community event about the drug deactivation pouches and 116 accepted at least 1 pouch (68.2% acceptance rate). In the second wave, 124 community members were approached by Community Health Workers; 100% accepted the pouch. Overall, the acceptance rate was 81.6%. People mentioned significant interest in using the pouches. Furthermore, surveys that assessed community members’ intention to use the deactivation pouches showed that 48% intended to use the pouch.
CONCLUSIONS AND RELEVANCE: The distribution of drug deactivation pouches is feasible in a community setting and although community members expressed interest in using drug deactivation pouches to dispose of unused opioid analgesics and other drugs, the majority still disposed of their unused medications through other avenues. This, underscore the need to raise community members’ awareness about the importance, benefits, and viability of these pouches as a tool for the primary prevention of opioid overdose because of their ease of use, safety, environmental considerations, and cost-effectiveness.